chr12-51786554-G-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_014191.4(SCN8A):c.3955G>T(p.Ala1319Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. A1319A) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 33)
Consequence
SCN8A
NM_014191.4 missense
NM_014191.4 missense
Scores
13
5
1
Clinical Significance
Conservation
PhyloP100: 10.0
Genes affected
SCN8A (HGNC:10596): (sodium voltage-gated channel alpha subunit 8) This gene encodes a member of the sodium channel alpha subunit gene family. The encoded protein forms the ion pore region of the voltage-gated sodium channel. This protein is essential for the rapid membrane depolarization that occurs during the formation of the action potential in excitable neurons. Mutations in this gene are associated with cognitive disability, pancerebellar atrophy and ataxia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SCN8A. . Gene score misZ 0.78755 (greater than the threshold 3.09). Trascript score misZ 10.278 (greater than threshold 3.09). GenCC has associacion of gene with myoclonus, familial, 2, infantile convulsions and choreoathetosis, cognitive impairment with or without cerebellar ataxia, undetermined early-onset epileptic encephalopathy, complex neurodevelopmental disorder, developmental and epileptic encephalopathy, 13, benign familial infantile epilepsy, seizures, benign familial infantile, 5.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.92
PP5
Variant 12-51786554-G-T is Pathogenic according to our data. Variant chr12-51786554-G-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 207117.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN8A | NM_001330260.2 | c.3955G>T | p.Ala1319Ser | missense_variant | 22/27 | ENST00000627620.5 | NP_001317189.1 | |
SCN8A | NM_014191.4 | c.3955G>T | p.Ala1319Ser | missense_variant | 22/27 | ENST00000354534.11 | NP_055006.1 | |
SCN8A | NM_001177984.3 | c.3832G>T | p.Ala1278Ser | missense_variant | 21/26 | NP_001171455.1 | ||
SCN8A | NM_001369788.1 | c.3832G>T | p.Ala1278Ser | missense_variant | 21/26 | NP_001356717.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN8A | ENST00000354534.11 | c.3955G>T | p.Ala1319Ser | missense_variant | 22/27 | 1 | NM_014191.4 | ENSP00000346534 | P4 | |
SCN8A | ENST00000627620.5 | c.3955G>T | p.Ala1319Ser | missense_variant | 22/27 | 5 | NM_001330260.2 | ENSP00000487583 | A1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 09, 2020 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has been observed in individual(s) with clinical features of SCN8A-related conditions (PMID: 29655203, Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 207117). This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with serine at codon 1319 of the SCN8A protein (p.Ala1319Ser). The alanine residue is highly conserved and there is a moderate physicochemical difference between alanine and serine. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 04, 2013 | p.Ala1319Ser (GCC>TCC): c.3955 G>T in exon 22 of the SCN8A gene (NM_014191.3).The Ala1319Ser missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This variant is a non-conservative amino acid substitution of a non-polar Alanine residue with a polar Serine residue. This variant occurs at a highly conserved position between the S4 and S5 segments in the third transmembrane domain of the SCN8A protein and in silico analysis predicts this variant is probably damaging to the protein structure/function. However, to our knowledge, other missense mutations in the same region of the protein have not been reported in association with epilepsy. This variant has been observed de novo without verified parentage. The variant is found in INFANT-EPI panel(s). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;.;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M;.;.;.;M
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D;.;.
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;.;.
Sift4G
Uncertain
D;T;T;D;D
Polyphen
D;.;.;.;.
Vest4
MutPred
Loss of methylation at R1314 (P = 0.1188);.;.;.;Loss of methylation at R1314 (P = 0.1188);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at